相似文献
1
Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation.
Clin Immunol. 2008 Jul;128(1):23-30. doi: 10.1016/j.clim.2008.03.459. Epub 2008 May 2.
2
Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
J Autoimmun. 2013 Dec;47:83-93. doi: 10.1016/j.jaut.2013.08.009. Epub 2013 Oct 3.
3
Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice.
J Autoimmun. 2008 Jun;30(4):197-206. doi: 10.1016/j.jaut.2007.08.001. Epub 2007 Oct 18.
4
Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.
J Autoimmun. 2005 Dec;25(4):303-11. doi: 10.1016/j.jaut.2005.08.007. Epub 2005 Oct 24.
5
Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
Cell Immunol. 2012;273(2):133-9. doi: 10.1016/j.cellimm.2011.12.008. Epub 2012 Jan 2.
6
Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.
Eur J Immunol. 2005 Sep;35(9):2762-75. doi: 10.1002/eji.200526158.
7
High diversity in the TCR repertoire of GAD65 autoantigen-specific human CD4+ T cells.
J Immunol. 2015 Mar 15;194(6):2531-8. doi: 10.4049/jimmunol.1403031. Epub 2015 Feb 13.
8
Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65).
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1763-8. doi: 10.1073/pnas.98.4.1763.
9
GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
J Autoimmun. 2005 Nov;25(3):235-43. doi: 10.1016/j.jaut.2005.09.018. Epub 2005 Nov 2.
10
Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.
Diabetes. 2010 Apr;59(4):947-57. doi: 10.2337/db09-0498. Epub 2010 Jan 19.
引用本文的文献
1
Cutting edge of immune response and immunosuppressants in allogeneic and xenogeneic islet transplantation.
Front Immunol. 2024 Sep 13;15:1455691. doi: 10.3389/fimmu.2024.1455691. eCollection 2024.
2
Transplantation: platform to study recurrence of disease.
Front Immunol. 2024 Mar 1;15:1354101. doi: 10.3389/fimmu.2024.1354101. eCollection 2024.
3
First World Consensus Conference on pancreas transplantation: Part II - recommendations.
Am J Transplant. 2021 Sep;21 Suppl 3(Suppl 3):17-59. doi: 10.1111/ajt.16750. Epub 2021 Jul 29.
4
Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes.
Acta Biomater. 2021 Oct 1;133:87-101. doi: 10.1016/j.actbio.2021.05.039. Epub 2021 Jun 5.
5
Immunological Monitoring in Beta Cell Replacement: Towards a Pathophysiology-Guided Implementation of Biomarkers.
Curr Diab Rep. 2021 Apr 25;21(6):19. doi: 10.1007/s11892-021-01386-4.
6
Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes.
Front Endocrinol (Lausanne). 2021 Mar 11;12:636824. doi: 10.3389/fendo.2021.636824. eCollection 2021.
7
The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes.
Front Immunol. 2021 Feb 2;11:615371. doi: 10.3389/fimmu.2020.615371. eCollection 2020.
8
Engineering immunomodulatory biomaterials for type 1 diabetes.
Nat Rev Mater. 2019 Jun;4(6):429-450. doi: 10.1038/s41578-019-0112-5. Epub 2019 May 17.
9
Autoimmune Diabetes Recurrence After Pancreas Transplantation: Diagnosis, Management, and Literature Review.
Ann Transplant. 2019 Nov 26;24:608-616. doi: 10.12659/AOT.920106.
10
A pilot study of preproinsulin peptides reactivity in Chinese patients with type 1 diabetes.
Diabetes Metab Res Rev. 2020 Feb;36(2):e3228. doi: 10.1002/dmrr.3228. Epub 2019 Nov 10.
本文引用的文献
1
Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes.
J Immunol. 2007 Nov 1;179(9):5785-92. doi: 10.4049/jimmunol.179.9.5785.
2
Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.
Clin Exp Immunol. 2007 Apr;148(1):1-16. doi: 10.1111/j.1365-2249.2006.03244.x.
3
Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients.
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2831-6. doi: 10.1073/pnas.0608610104. Epub 2007 Feb 16.
4
Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DR beta 1*0402 tetramers.
Clin Immunol. 2007 Mar;122(3):330-7. doi: 10.1016/j.clim.2006.09.014. Epub 2006 Nov 17.
5
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17414-9. doi: 10.1073/pnas.0605136103. Epub 2006 Nov 6.
6
HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.
J Clin Invest. 2006 Aug;116(8):2226-36. doi: 10.1172/JCI27620. Epub 2006 Jul 27.
7
Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes.
Diabetes. 2006 Jan;55(1):50-60.
8
GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
J Autoimmun. 2005 Nov;25(3):235-43. doi: 10.1016/j.jaut.2005.09.018. Epub 2005 Nov 2.
9
Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.
J Autoimmun. 2005 Dec;25(4):303-11. doi: 10.1016/j.jaut.2005.08.007. Epub 2005 Oct 24.
10
GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes.
Diabetes. 2004 Aug;53(8):1987-94. doi: 10.2337/diabetes.53.8.1987.
Zotero 插件